4-6 December 2013, Lisbon, Portugal
Bio-IT World and Cambridge Healthtech Institute's fifth international Clinical Genomics & Informatics Europe conference will feature four main tracks on Clinical Exome Sequencing, High Scale Computing, Genome Informatics, and RNA-Seq and Transcriptome Analysis, as well as two pre-conference symposia on Clinical Epigenetics and Quantitative Digital Detection Technologies. The conference will tackle the huge amounts of sequencing data produced by new technologies that have introduced significant challenges for bioinformatics, both in terms of the analysis and interpretation of data and clinical implementation of novel variants. Members of the international community will come together to look at the science and informatics required to utilize next generation sequencing for the molecular diagnosis of complex diseases.
17-20 November 2013, Davos, Switzerland
Following a very successful launch of the first GRF One Health Summit in February 2012, GRF Davos is pleased to announce the 2nd GRF One Health Summit 2013 which will take place from 17 - 20 November 2013 at the Davos Congress Centre in Davos, Switzerland.
The 2nd GRF One Health Summit will further explore, advance and agree on the need for a global integrative risk management approach for One Health. Furthermore, the conference will identify ways to achieve added value by multi-sectorial and multi-stakeholder cooperation and promote enhanced public-private partnership models for risk-based financing tools.
The findings of the conference shall be used to make recommendations on policy and organisational changes and stimulate a more efficient collaboration between stakeholders. Registration and Abstract Submission are open now.
Submit your abstract today and present at the 2nd GRF One Health Summit 2013. We encourage you to explore our website and get further information on the One Health concept and the 2nd GRF One Health Summit.
24 October 2013, Naples, Italy
The BIO-TIC partners, in collaboration with Assobiotec, are pleased to invite you to half a day workshop for an in-depth discussion with experts and multiple stakeholders across different value chains on how to overcome barriers for innovation in industrial biotechnology in Europe. Draft roadmaps outlining market potential, technological bottlenecks and non-technical barriers have already been developed through a preliminary literature review.
This workshop session aims to validate these roadmaps and identify:
- What are the barriers to the deployment of IB in Italy and Europe, and what can we do to overcome them?
- Are there any particular factors which make Italy a good place to establish or grow the IB industry?
In the workshop, we would like to share our knowledge with you and receive your recommendations. We would particularly like to hear your thoughts on what the most important barriers are and what innovations are, or could be developed, to overcome these barriers.
This workshop is one of a series of eight workshops to be held in 2013/14 throughout Europe. The results of these workshops will be incorporated into the draft roadmaps and will be supplemented with the results of one-on-one interviews. Your involvement will provide an opportunity to influence, shape and guide future regulatory and funding frameworks (e.g. BRIDGE PPP in HORIZON 2020), through your experience of the current landscape, your views and opinions on the key hurdles affecting your business and the current and future enablers encouraging the uptake of biotech innovation. It will be organized after the 2-days workshop “IFIB 2013, the Italian Forum on Industrial Biotechnology and Bioeconomy from biotechnology new resources for industry”.
To register, please fill in the form here.
17-18 October 2013, Prague
International conference to launch the Horizon 2020 programme entitled "The EU Horizon 2020 Programme and Teaming for Excellence in the European Research Area" (H2020-TEER), as its title suggests, will act not only on the structure of the program, but also the involvement of Czech research teams in collaboration with teams of excellent European research centers.